JORDAN C WILLIAMS
Allopathic & Osteopathic Physicians|Family Medicine NEW BRAUNFELS, TX NPI 1326334871
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Novo Nordisk AS All categories
General Payments — all program years on this page
$6,115.59
- Category: General Payments
- Program years: PY2018–2024
- Record count: 371
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,294.54 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,294.54 | 69 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $202.14 | 10 |
| PFIZER INC. | $181.61 | 11 |
| Lilly USA, LLC | $178.36 | 8 |
| Exact Sciences Corporation | $118.59 | 6 |
| Acerta Pharma LLC | $88.34 | 5 |
| GlaxoSmithKline, LLC. | $85.58 | 5 |
| ABBVIE INC. | $77.87 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $55.77 | 4 |
| Amgen Inc. | $47.33 | 3 |
| GENZYME CORPORATION | $30.60 | 1 |
| Esperion Therapeutics, Inc. | $30.07 | 2 |
| Corcept Therapeutics | $26.68 | 1 |
| Abbott Laboratories | $22.17 | 1 |
| Astellas Pharma US Inc | $22.06 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.22 | 1 |
| Kowa Pharmaceuticals America, Inc. | $20.29 | 1 |
| Merck Sharp & Dohme Corporation | $19.27 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.26 | 1 |
| Nevro Corp. | $17.06 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.30 | 1 |
| Antares Pharma, Inc. | $14.97 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.